Medical News

RSS

eHealth Ontario and OntarioMD partner to implement the "EMR Adoption Program"

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, is pleased to report that the Ontario Medical Association (OMA) announced to its physician members that it has successfully negotiated $236 million in funding with the government of Ontario to advance the adoption of electronic medical records (EMRs) among practice-based family physicians and specialists in the province.

29 Oct 2009

Phase Forward’s InForm GTM electronic data capture solution to be implemented by Bausch & Lomb

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward’s InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.

29 Oct 2009

Health bills present formidable challenges to numbers crunchers

The House Democratic leadership is expected to unveil its health-overhaul legislation Thursday, the Associated Press reports. The next step will be for the merged bill - consolidated from three separate committee reports - to go to the Congressional Budget Office for a cost estimate, before lawmakers vote. In the Senate, Majority Leader Harry Reid is awaiting the CBO's analysis of his bill, before taking it to the floor (10/29).

29 Oct 2009

Geisinger's orthopaedics department awarded $97,000 grant for expanding its advanced medical home study

A Geisinger orthopaedic surgeon recently received a $97,000 grant from the Orthopaedic Trauma Association for a pilot study that will expand Geisinger's ProvenHealth Navigator advanced medical home to include care for patients recovering from hip fractures.

29 Oct 2009

Pelosi chooses compromise approach to public option in reform bill

A health care reform bill set to be unveiled this morning will include a government-run public option for health insurance that will negotiate rates with insurers, much like private insurers operate.

29 Oct 2009

Allergan reports operating results for the third quarter of 2009

Allergan, Inc. today announced operating results for the quarter ended September 30, 2009. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on November 30, 2009 to stockholders of record on November 9, 2009.

29 Oct 2009

Black AIDS Institute and CDC leaders finalize grant details for African American HIV University

Leaders from the Black AIDS Institute and the Centers for Disease Control and Prevention (CDC) met recently to finalize the details of a four and one-half year grant to fund the Institute's African American HIV University (AAHU) Community Mobilization College.

29 Oct 2009

Varian Medical Systems to showcase future technologies for managing cancer at the ASTRO

New technology enhancements from Varian Medical Systems, designed to make radiotherapy and radiosurgery treatments faster, more accurate, and easier to plan and deliver, will be on display at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Chicago next week.

29 Oct 2009

CryoLife reports a net income of $1.9 million for the third quarter of 2009

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the third quarter of 2009 increased 5 percent to a quarterly record of $28.2 million compared to $26.8 million for the third quarter of 2008.

29 Oct 2009

Inhibitex completes $23 million private placement of common stock and warrants

Inhibitex, Inc. today reported the completion of its previously announced $23 million private placement of common stock and warrants. Investors in the private placement purchased units, each consisting of one share of common stock and a warrant to purchase .45 of a share of common stock, at a purchase price of $1.28 per unit, which is equal to the consolidated closing bid price of the common stock as reported on the NASDAQ Capital Market for October 22, 2009, plus $0.06.

29 Oct 2009

World’s first Cesium-131 lung implants performed

IsoRay, Inc. announced today that starting on August 12, 2009, Dr. Bhupesh Parashar from the Department of Radiation Oncology, and Dr. Nasser Altorki of the Department of Cardiothoracic Surgery at Weill Cornell Medical Center performed the world’s first Cesium-131 lung implants.

29 Oct 2009

Health bills limit out-of-pocket costs, but there's a catch in the fine print

Health care bills pending in Congress could limit the out-of-pocket costs for consumers, but some of the fine print may cause sticker shock. "Consumers would be spared having to pay huge medical bills under Democratic health care legislation that's moving through Congress, as lawmakers agree on the need to put limits on how much people would pay out of their own pockets," McClatchy reports.

29 Oct 2009

ETMC to implement Unibased's Consumer Access and Scheduling for Healthcare web application

East Texas Medical Center (ETMC) has announced its selection of Unibased Systems Architecture, Inc. (Unibased) consumer portal, Consumer Access and Scheduling for Healthcare (CASH) to simplify and expedite access for services. The web application is fully integrated with the Unibased ForSite2020® product suite and it will improve the access process. Providing 24/7 web access to service scheduling and registration eliminates several of the impediments consumers experience in obtaining their healthcare needs.

29 Oct 2009

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today its participation in a $2.4 million research grant awarded to the University of Pennsylvania under the “American Recovery and Reinvestment Act of 2009”. The new grant will fund research over two years in the laboratories of Daniel Rader, M.D. of the University of Pennsylvania School of Medicine, Sekar Kathiresan, M.D. of Massachusetts General Hospital (MGH) and Harvard Medical School, and Alnylam.

29 Oct 2009

Gamma Pharmaceuticals completes the registration of six of its Brand Trademarks in China

Gamma Pharmaceuticals Inc. (the "Company") announced it has successfully completed the registration of six of the Company's Brand Trademarks with The State Trademark Bureau of China.

29 Oct 2009

Amorfix Life Sciences achieves 100% specificity in using EP-vCJD Blood Screening Assay

Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.

29 Oct 2009

Novian Health and Rose Medical Center sign an agreement to provide Novilase laser treatment to treat breast lumps

Novian Health, manufacturer of Novilase™ Breast Therapy for benign breast tumors, announced an agreement with Rose Medical Center for Rose to provide the Novilase laser treatment to treat breast lumps.

29 Oct 2009

Merge Healthcare reports fiscal 2009 third-quarter results

Merge Healthcare Incorporated, a health IT solutions provider, today announced financial results for the third quarter of 2009.

29 Oct 2009

Third-quarter fiscal 2009 results announced by Adolor

Adolor Corporation today reported a net loss of approximately $11.1 million, or ($0.24) per basic and diluted share, for the three months ended September 30, 2009 compared to a net loss of $13.3 million, or ($0.29) per basic and diluted share, for the three months ended September 30, 2008.

29 Oct 2009

ZyGEM signs an agreement with VERITAS Japan to distribute DNA extraction products to the Japanese market

ZyGEM Corp. Ltd., a provider of innovative enzyme-based products for DNA extraction and other life sciences applications, today announced it has entered into an exclusive agreement with VERITAS Japan to distribute ZyGEM's DNA extraction products to the Japanese market.

29 Oct 2009

Medical News

eHealth Ontario and OntarioMD partner to implement the "EMR Adoption Program"

Phase Forward’s InForm GTM electronic data capture solution to be implemented by Bausch & Lomb

Health bills present formidable challenges to numbers crunchers

Geisinger's orthopaedics department awarded $97,000 grant for expanding its advanced medical home study

Pelosi chooses compromise approach to public option in reform bill

Allergan reports operating results for the third quarter of 2009

Black AIDS Institute and CDC leaders finalize grant details for African American HIV University

Varian Medical Systems to showcase future technologies for managing cancer at the ASTRO

CryoLife reports a net income of $1.9 million for the third quarter of 2009

Inhibitex completes $23 million private placement of common stock and warrants

World’s first Cesium-131 lung implants performed

Health bills limit out-of-pocket costs, but there's a catch in the fine print

ETMC to implement Unibased's Consumer Access and Scheduling for Healthcare web application

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

Gamma Pharmaceuticals completes the registration of six of its Brand Trademarks in China

Amorfix Life Sciences achieves 100% specificity in using EP-vCJD Blood Screening Assay

Novian Health and Rose Medical Center sign an agreement to provide Novilase laser treatment to treat breast lumps

Merge Healthcare reports fiscal 2009 third-quarter results

Third-quarter fiscal 2009 results announced by Adolor

ZyGEM signs an agreement with VERITAS Japan to distribute DNA extraction products to the Japanese market

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News